نتایج جستجو برای: pancreatic cancer

تعداد نتایج: 965800  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Kenoki Ohuchida Kazuhiro Mizumoto Seiji Ohhashi Hiroshi Yamaguchi Hiroyuki Konomi Eishi Nagai Koji Yamaguchi Masazumi Tsuneyoshi Masao Tanaka

PURPOSE Recent microarray analyses revealed that expression of S100A11 is up-regulated in pancreatic cancer. The aim of the present study was to evaluate the association of S100A11 with pancreatic carcinogenesis. EXPERIMENTAL DESIGN We measured S100A11 mRNA expression in various clinical samples related to pancreatic cancer and its precursor lesions, intraductal papillary mucinous neoplasm (I...

Journal: :Journal of Student Research 2023

Pancreatic cancer, among which pancreatic ductal adenocarcinoma (PDAC) is the most common type, has a nearly identical incidence to mortality rate. Difficulties in early detection, diagnosis, and treatment are primarily responsible, all of further complicated by molecular biology etiology disease. To succeed improving options survival rates, deeper understanding cancer pathogenesis, as well pat...

2013
Chang Moo Kang Ho Kyoung Hwang Woo Jung Lee

This manuscript summarized one section out of the international symposium, Pancreatic Cancer 2012, which was held last October 4th through 6th in Kyoto (Japan) under the theme, "We are the Team: Opening the Door to the Next Step for Pancreatic Cancer Therapy." Borderline resectable pancreatic cancer (BRPC) is a specific clinical presentation with features in between those of resectable and loca...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Kenoki Ohuchida Kazuhiro Mizumoto Nami Ishikawa Kei Fujii Hiroyuki Konomi Eishi Nagai Koji Yamaguchi Masazumi Tsuneyoshi Masao Tanaka

Recent microarray analyses showed that the S100 family contains members that are candidate diagnostic markers or therapeutic targets. In the present study, to evaluate the involvement of S100A6 in pancreatic cancer and its clinical usefulness for diagnosis, we examined S100A6 mRNA expression in pancreatic tissues and pancreatic juice from patients with different pancreatic diseases. To investig...

Journal: :Cancer research 2003
Craig D Logsdon Diane M Simeone Charles Binkley Thiruvengadam Arumugam Joel K Greenson Thomas J Giordano David E Misek Rork Kuick Samir Hanash

The molecular basis of pancreatic cancer is not understood. Previous attempts to determine the specific genes expressed in pancreatic cancer have been hampered by similarities between adenocarcinoma and chronic pancreatitis. In the current study, microarrays (Affymetrix) were used to profile gene expression in pancreatic adenocarcinoma (10), pancreatic cancer cell lines (7), chronic pancreatiti...

2003
Craig D. Logsdon Diane M. Simeone Charles Binkley Thiruvengadam Arumugam Joel K. Greenson Thomas J. Giordano David E. Misek Samir Hanash

The molecular basis of pancreatic cancer is not understood. Previous attempts to determine the specific genes expressed in pancreatic cancer have been hampered by similarities between adenocarcinoma and chronic pancreatitis. In the current study, microarrays (Affymetrix) were used to profile gene expression in pancreatic adenocarcinoma (10), pancreatic cancer cell lines (7), chronic pancreatiti...

Journal: :Journal of cellular and molecular medicine 2015
Qingqu Guo Wenjie Qin

The Wnt/β-catenin signalling pathway is activated in pancreatic cancer initiation and progression. Dickkopf-related protein 3 (DKK3) is a member of the human Dickkopf family and an antagonist of Wnt ligand activity. However, the function of DKK3 in this pathway in pancreatic cancer is rarely known. We examined the expression of DKK3 in six human pancreatic cancer cell lines, 75 pancreatic cance...

Journal: :Cancer research 2010
Michele L Scotti William R Bamlet Thomas C Smyrk Alan P Fields Nicole R Murray

Pancreatic cancer is the fourth leading cause of cancer deaths in the United States, with an overall 5-year survival rate of <5%. Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, is highly resistant to conventional chemotherapies, underscoring the critical need for new molecular targets for pancreatic cancer chemotherapy. The KRAS proto-oncogene is mutated in ...

2016
Yiwei Li Fazlul H. Sarkar

Pancreatic cancer remains the fourth leading cause of cancer-related death in the US and is expected to be the second leading cause of cancer-related death by 2030. Therefore, it is important to better understand the molecular pathogenesis, phenotypes and features of pancreatic cancer in order to design novel molecularly targeted therapies for achieving better therapeutic outcome of patients wi...

Journal: :The American journal of pathology 2003
Christine A Iacobuzio-Donahue Anirban Maitra Mari Olsen Anson W Lowe N Tjarda van Heek Christophe Rosty Kim Walter Norihiro Sato Antony Parker Raheela Ashfaq Elizabeth Jaffee Byungwoo Ryu Jessa Jones James R Eshleman Charles J Yeo John L Cameron Scott E Kern Ralph H Hruban Patrick O Brown Michael Goggins

Pancreatic cancer is the fifth leading cause of cancer death in the United States. We used cDNA microarrays to analyze global gene expression patterns in 14 pancreatic cancer cell lines, 17 resected infiltrating pancreatic cancer tissues, and 5 samples of normal pancreas to identify genes that are differentially expressed in pancreatic cancer. We found more than 400 cDNAs corresponding to genes...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید